Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Payables (2022 - 2025)

ASP Isotopes has reported Payables over the past 4 years, most recently at $5.8 million for Q4 2025.

  • On a quarterly basis, Payables rose 193.61% to $5.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.8 million, a 193.61% increase, with the full-year FY2025 number at $5.8 million, up 193.61% from a year prior.
  • Payables reached $5.8 million in Q4 2025 per ASPI's latest filing, up from $3.4 million in the prior quarter.
  • The five-year high for Payables was $5.8 million in Q4 2025, with the low at $13046.0 in Q1 2022.
  • The 4-year median for Payables is $1.8 million (2024), against an average of $2.0 million.
  • The largest YoY upside for Payables was 3225.57% in 2023 against a maximum downside of 63.38% in 2023.
  • Tracing ASPI's Payables over 4 years: stood at $1.4 million in 2022, then grew by 13.93% to $1.6 million in 2023, then increased by 23.88% to $2.0 million in 2024, then soared by 193.61% to $5.8 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $5.8 million, $3.4 million, and $2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.